Amy Holroyd
Impact in
-
- Multiple Myeloma Research and Treatments
-
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- Renal and related cancers
Papers in
-
- Protein Degradation and Inhibitors 4
- Cancer therapeutics and mechanisms 1
-
- Multiple Myeloma Research and Treatments 3
- Co-authors
- Richard S. Houlston (5 shared papers)Mark T. Drayson (3 shared papers)Robert Huddart (2 shared papers)Rosalind A. Eeles (2 shared papers)Martin Kaiser (3 shared papers)Douglas F. Easton (2 shared papers)Darshna Dudakia (2 shared papers)Roger G. Owen (3 shared papers)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Amy Holroyd
4 papers receiving 53 citations
Peers
Comparison fields: 5 of 18
- Hematology 25
- Molecular Biology 45
- Reproductive Medicine 5
- Genetics 12
- Oncology 10
Countries citing papers authored by Amy Holroyd
This map shows the geographic impact of Amy Holroyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Holroyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Holroyd more than expected).
Fields of papers citing papers by Amy Holroyd
This network shows the impact of papers produced by Amy Holroyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Holroyd. The network helps show where Amy Holroyd may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Holroyd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 22 | |
| 2 | 2022 | 21 | |
| 3 | 2017 | 6 | |
| 4 | 2023 | 5 | |
| 5 | 2024 | 0 |
About Amy Holroyd
Amy Holroyd is a scholar working on Molecular Biology, Hematology, Surgery, Oncology and Genetics, having authored 5 papers that have together received 54 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (3 papers), Testicular diseases and treatments (2 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (2 papers), Cancer Treatment and Pharmacology (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Cancer therapeutics and mechanisms (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Hematology (25 citations), Molecular Biology (45 citations), Reproductive Medicine (5 citations), Genetics (12 citations) and Oncology (10 citations). Amy Holroyd has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Richard S. Houlston, Mark T. Drayson, Robert Huddart, Rosalind A. Eeles, Martin Kaiser, Douglas F. Easton, Darshna Dudakia, Roger G. Owen, Graham Jackson and Kevin Litchfield. Their work appears in journals such as Blood, Nature Communications and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.